BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30266686)

  • 1. Further delineation of AGPAT2 and BSCL2 related congenital generalized lipodystrophy in young infants.
    Liu Y; Li D; Ding Y; Kang L; Jin Y; Song J; Li H; Yang Y
    Eur J Med Genet; 2019 Sep; 62(9):103542. PubMed ID: 30266686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Japanese infants with congenital generalized lipodystrophy due to BSCL2 mutations.
    Nishiyama A; Yagi M; Awano H; Okizuka Y; Maeda T; Yoshida S; Takeshima Y; Matsuo M
    Pediatr Int; 2009 Dec; 51(6):775-9. PubMed ID: 19438831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
    Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
    Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in Gng3lg and AGPAT2 in Berardinelli-Seip congenital lipodystrophy and Brunzell syndrome: phenotype variability suggests important modifier effects.
    Fu M; Kazlauskaite R; Baracho Mde F; Santos MG; Brandão-Neto J; Villares S; Celi FS; Wajchenberg BL; Shuldiner AR
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2916-22. PubMed ID: 15181077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.
    Akinci B; Onay H; Demir T; Ozen S; Kayserili H; Akinci G; Nur B; Tuysuz B; Nuri Ozbek M; Gungor A; Yildirim Simsir I; Altay C; Demir L; Simsek E; Atmaca M; Topaloglu H; Bilen H; Atmaca H; Atik T; Cavdar U; Altunoglu U; Aslanger A; Mihci E; Secil M; Saygili F; Comlekci A; Garg A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2759-67. PubMed ID: 27144933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Patient with Berardinelli-Seip Syndrome, Novel
    Oswiecimska J; Dawidziuk M; Gambin T; Ziora K; Marek M; Rzonca S; Guilbride DL; Jhangiani SN; Obuchowicz A; Sikora A; Lupski JR; Wiszniewski W; Gawlinski P
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):319-326. PubMed ID: 30563316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion mutation in BSCL2 gene underlies congenital generalized lipodystrophy in a Pakistani family.
    Rahman OU; Khawar N; Khan MA; Ahmed J; Khattak K; Al-Aama JY; Naeem M; Jelani M
    Diagn Pathol; 2013 May; 8():78. PubMed ID: 23659685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
    Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel BSCL2 gene mutation E189X in Chinese congenital generalized lipodystrophy child with early onset diabetes mellitus.
    Jin J; Cao L; Zhao Z; Shen S; Kiess W; Zhi D; Ye R; Cheng R; Chen L; Yang Y; Luo F
    Eur J Endocrinol; 2007 Dec; 157(6):783-7. PubMed ID: 18057387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Mutational Features of Three Chinese Children with Congenital Generalized Lipodystrophy.
    Su X; Lin R; Huang Y; Sheng H; Li X; Ting TH; Liu L; Li X
    J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):52-57. PubMed ID: 27612026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation.
    Friguls B; Coroleu W; del Alcazar R; Hilbert P; Van Maldergem L; Pintos-Morell G
    Eur J Med Genet; 2009; 52(1):14-6. PubMed ID: 19041432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
    Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
    Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel compound heterozygous variant of BSCL2 identified by whole exome sequencing and multiplex ligation‑dependent probe amplification in an infant with congenital generalized lipodystrophy.
    Xie B; Fan X; Lei Y; Yi S; Yang Q; Wang J; Qin Z; Shen F; Luo J; Shen Y
    Mol Med Rep; 2020 Jun; 21(6):2296-2302. PubMed ID: 32236581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular characterization of two Chinese patients with Type 2 congenital generalized lipodystrophy.
    Chen R; Yuan X; Wang J; Zhang Y
    Gene; 2017 Dec; 637():57-62. PubMed ID: 28916377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic basis of congenital generalized lipodystrophy.
    Agarwal AK; Barnes RI; Garg A
    Int J Obes Relat Metab Disord; 2004 Feb; 28(2):336-9. PubMed ID: 14557833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Taiwanese boy with congenital generalized lipodystrophy caused by homozygous Ile262fs mutation in the BSCL2 gene.
    Huang HH; Chen TH; Hsiao HP; Huang CT; Wang CC; Shiau YH; Chao MC
    Kaohsiung J Med Sci; 2010 Nov; 26(11):615-20. PubMed ID: 21126715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1.
    Haghighi A; Razzaghy-Azar M; Talea A; Sadeghian M; Ellard S; Haghighi A
    Eur J Med Genet; 2012 Nov; 55(11):620-4. PubMed ID: 22902344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted massively parallel sequencing for congenital generalized lipodystrophy.
    Costa-Riquetto AD; Santana LS; Caetano LA; Lerário AM; Correia-Deur JEM; Bertola DR; Kim CA; Nery M; Jorge AAL; Teles MG
    Arch Endocrinol Metab; 2021 May; 64(5):559-566. PubMed ID: 34033296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
    Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
    Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital generalized lipodystrophy: identification of novel variants and expansion of clinical spectrum.
    Haghighi A; Kavehmanesh Z; Haghighi A; Salehzadeh F; Santos-Simarro F; Van Maldergem L; Cimbalistiene L; Collins F; Chopra M; Al-Sinani S; Dastmalchian S; de Silva DC; Bakhti H; Garg A; Hilbert P
    Clin Genet; 2016 Apr; 89(4):434-441. PubMed ID: 26072926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.